Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097578 · ClinicalTrials.gov registry record
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
- 1,953
- Enrollment target
NCT00097578 is a clinical trial that has completed, run by Genentech. The registered enrollment target is 1,953 participants.
The verdict
NCT00097578 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 1,953 participants
- Enrollment target
Study Summary
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated \<=4 months prior to enrollment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,953 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00097578
The ClinicalTrials.gov registry entry for NCT00097578 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,953 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00097578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00097578 about?
NCT00097578 is a clinical study titled "A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma". This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated \<=4 months prior to enrollment.
What is the current status of trial NCT00097578?
This trial is currently completed. The enrollment target is 1,953 participants. The study started on 2004-03. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00097578?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.